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Abstract
Background: People living with human immunodeficiency virus (PLHIV) struggle with the challenges of living with
a chronic disease and integrating antiretroviral treatment (ART) and care into their daily lives. The aims of this study
were as follows: (1) to undertake the first mega-aggregation of qualitative evidence syntheses using the methods of
framework synthesis and (2) make sense of existing qualitative evidence syntheses that explore the barriers and
facilitators of adherence to antiretroviral treatment, linkage to care and retention in care for PLHIV to identify
research gaps.
Methods: We conducted a comprehensive search and did all screening, data extraction and critical appraisal
independently and in duplicate. We used the Kaufman HIV Behaviour Change model (Kaufman et al., 2014) as a
framework to synthesise the findings using the mega-aggregative framework synthesis approach, which consists of
8 steps: (1) identify a clearly defined review question and objectives, (2) identify a theoretical framework or model,
(3) decide on criteria for considering reviews for inclusion, (4) conduct searching and screening, (5) conduct quality
appraisal of the included studies, (6) data extraction and categorisation, (7) present and synthesise the findings, and
(8) transparent reporting. We evaluated systematic reviews up to July 2018 and assessed methodological quality,
across reviews, using the Joanna Briggs Institute Critical Appraisal Checklist for Systematic Reviews.
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Results: We included 33 systematic reviews from low, middle- and high-income countries, which reported on 1,
111,964 PLHIV. The methodological quality of included reviews varied considerably. We identified 544 unique third-
order concepts from the included systematic reviews, which were reclassified into 45 fourth-order themes within
the individual, interpersonal, community, institutional and structural levels of the Kaufman HIV Behaviour Change
model. We found that the main influencers of linkage, adherence and retention behaviours were psychosocial and
personal characteristics—perceptions of ART, desires, fears, experiences of HIV and ART, coping strategies and
mental health issues—interwoven with other factors on the interpersonal, community, institutional and structural
level. Using this approach, we found interdependence between factors influencing ART linkage, retention and
adherence and identified the need for qualitative evidence that explores, in greater depth, the complex
relationships between structural factors and adherence, sociodemographic factors such as community violence and
retention, and the experiences of growing up with HIV in low- and middle-income countries—specifically in
children, youth, women and key populations.
Conclusions: This is the first mega-aggregation framework synthesis, or synthesis of qualitative evidence syntheses
using the methods of framework synthesis at the overview level. We found the novel method to be a transparent
and efficient method for assessing the quality and making sense of existing qualitative systematic reviews.
Systematic review registration: The protocol of this overview was registered on PROSPERO (CRD42017078155) on
17 December 2017.
Keywords: Overview, Mega-aggregation, Qualitative, Synthesis, Human immunodeficiency virus, Linkage,
Adherence, Retention, ART
Background
Qualitative evidence syntheses (QES) aggregate, integrate
and interpret results from primary qualitative studies [1].
Like quantitative systematic reviews, QES follow transparent,
systematic and rigorous methods. With the increase in num-
ber of QES on HIV adherence research [2], the next step is
to provide an overview of existing systematic reviews to iden-
tify research gaps and an up-to-date synthesis of what is
known. An overview is also referred to by names such as an
umbrella review or a review of reviews. Methods of QES are
complex and continue to develop [3]. Although there is guid-
ance on summarising qualitative systematic reviews [4, 5],
the application of the guidance to cases is still emerging in
the literature, with examples of meta-summary of reviews [6,
7] and an application of mega-ethnography [8]. To consider
evidence with the aim of assessing the quality of the existing
evidence, identifying research gaps to formulate new research
questions, or to make decisions about best practice, the ap-
propriate QES method would be meta-aggregation. Meta-
aggregation does not aim to produce deeper interpretative
analysis of the data extracted from the primary studies but
rather summarises findings to produce recommendations for
action [9, 10]. Introducing an existing theory or framework
[11] into this process can contribute to the efficiency, rigour
and pragmatism of meta-aggregation. In this study, we illus-
trate mega-aggregation framework synthesis to make sense
of existing qualitative systematic reviews.
Exploring barriers and facilitators of antiretroviral therapy
Although access to HIV care has improved significantly
over the past few years, people living with HIV (PLHIV)
still face numerous challenges when it comes to initiating
care and staying on treatment. Human immunodeficiency
virus (HIV) represents one of the greatest global public
health challenge in history, and since the beginning of the
epidemic, approximately 78 million people worldwide
have been infected with HIV and 35 million people have
died [12]. The Joint United Nations Programme on HIV/
acquired immunodeficiency syndrome (AIDS) (UNAIDS)
set the global 90-90-90-target to combat HIV infection by
2020 [13]. The goal aims for 90% of all people to know
their HIV status, of those who test positive, 90% should be
linked to care, and of those being adherent to care, 90%
will have achieved viral suppression. Nearly 37 million
people were estimated to be living with HIV worldwide in
2017; however, only 60% were aware of their HIV status
and only 49% of those who knew their status were acces-
sing treatment [14]. The HIV burden varies considerably
between countries, with regions in Africa having the high-
est HIV prevalence with HIV being the leading cause of
death in South Africa [12]. To date there is no known cure
for AIDS. However, being linked to care and adhering to
antiretroviral therapy (ART) has been shown to improve
quality of life for PLHIV, and in most cases provided simi-
lar life expectancy periods for those without HIV [15, 16].
Why it is important to do this overview
PLHIV continue to be challenged by the complexities re-
lated to being HIV positive and integrating ART treat-
ment and care into their daily lives. Unsuccessful
interventions and the target driven 90-90-90 goals have
increased researchers’ commitment to understanding the
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human experience of living with HIV and engaging in
the HIV treatment cascade. Some reviews have focused
only on prevention, adherence, linkage to care or reten-
tion in care. This can lead to an abundance of research
in one area on the cascade and neglect of others. With
the growing body of existing systematic reviews [17, 18],
there is no coherent sense of what is already known
across populations and settings, and there is uncertainty
about the quality of the existing evidence. This can make
it hard for policy makers and practitioners to make
evidence-informed decisions. However, the increase in
QES makes research innovation in the synthesis of quali-
tative review-level evidence possible. The overarching
aim of this study is to debut the first application of
mega-aggregation framework synthesis to qualitative sys-
tematic review-level evidence. This method of summar-
ising QES in an overview will be applied to review-level
evidence of barriers and facilitators of linkage to care,
adherence to ART and retention in care for PLHIV in
low-, middle- and high-income countries.
Methods
Paradigmatic stance
Overviews of reviews aim to provide a single synthesis
or summary from multiple systematic reviews [19]. QES
often have a theoretical underpinning to understand
findings and interpret meaning. Qualitative research is
usually positioned in the interpretive or critical-realist
paradigm. Another approach to QES is meta-
aggregation, which is based on the philosophy of prag-
matism [20, 21] and users of this method aim for imme-
diate usability of the review findings. This study
proposes the application of mega-aggregation, which,
unlike mega-ethnography, does not focus on the gener-
ation of new theory nor aims to provide deepened con-
ceptual interpretations of findings [8], but rather aims to
provide an overview of the existing evidence, identify
evidence gaps and make recommendations for future re-
search or immediate action [21, 22].
Overview design
In the context of the pragmatic stance and the anticipated
large number of existing systematic reviews, a predeter-
mined theoretical framework [23] with broad categories
was selected to guide the aggregation and synthesis within
this overview, which built on the steps in methods devel-
opment for conducting overviews [24], QES [25, 26], sys-
tematic review synthesis [19, 27, 28], meta-aggregation [9,
20, 21] and framework synthesis [29, 30]. The novel ap-
proach of mega-aggregation framework synthesis was de-
veloped and utilised to identify evidence gaps and to
inform future research from the evidence collated within
included systematic reviews. The mega-aggregative frame-
work synthesis approach consists of eight distinct steps
(Fig. 1). The steps are as follows: (1) identify a clearly de-
fined review question and objectives, (2) identify a theoret-
ical framework or model, (3) decide on criteria for
considering reviews for inclusion, (4) conduct searching
and screening, (5) conduct quality appraisal of the in-
cluded studies (although some may prefer not too), (6)
data extraction and categorisation, (7) present and synthe-
sise the findings, and (8) transparent reporting.
Step 1: identifying a clearly defined research question and
objectives
This study aimed to answer the question:
What is the available review-level evidence of the self-
reported barriers and facilitators to linkage, adherence to
ART and retention in care, for people living with HIV in
low-, middle- and high-income countries?
The primary objective was to gather, appraise and syn-
thesise the systematic review-level evidence on the bar-
riers and facilitators on behaviours related to ART
among PLHIV using Kaufmans’ HIV Behaviour Change
model [23]. The secondary objective was to identify evi-
dence gaps for self-reported barriers and facilitators
among PLHIV to create lines of action and make recom-
mendations for future research, policy, and practice.
Step 2: identifying a theoretical framework or model
The complexities and interrelatedness of the factors in-
fluencing behaviour of PLHIV, including barriers and fa-
cilitators, can be found in multiple dimensions for
linkage to ART [31], adherence to ART [32–34] and re-
tention in care [35, 36]. The dimensions within which
barriers and facilitators are understood in this overview
are based on the Kaufman and colleagues HIV Behav-
iour Change Model [23]. The framework includes five
broad domains, namely: (1) individual factors (includes
factors such as knowledge, emotions, motivation, mental
health, adverse drug reactions and comorbidities), (2)
interpersonal and network factors (includes factors such
as relationships, social networks and interpersonal vio-
lence, (3) community factors (includes factors such as
stigma, peer pressure and cultural norms), (4) institu-
tional and health system factors, (includes factors such
as provision of services, service integration and relation-
ships with health care workers), and (5) structural fac-
tors (includes factors such as poverty, political context
and gender equity). This framework is useful to this
overview as it provides comprehensive multi-level do-
mains to understand the barriers and facilitators that
PLHIV experience when they decide to link to ART, ad-
here to ART and engage in care consistently.
Step 3: criteria for considering systematic reviews for
inclusion
Types of reviews
Hendricks et al. Systematic Reviews           (2021) 10:54 Page 3 of 28
Systematic reviews were defined as those reviews that
had predetermined objectives, predetermined criteria for
eligibility, searched at least two data sources, of which
one needed to be an electronic database, and performed
standardised data extraction [37].
Systematic reviews were considered eligible if they in-
cluded only qualitative studies. Reviews containing quali-
tative and quantitative studies were still considered
eligible if outcomes were self-reported and a narrative
description was used to summarise review findings. Sys-
tematic reviews only synthesising quantitative studies or
only examining adherence pre- or post-exposure
prophylaxis were excluded. No reviews were excluded
based on whether quality assessments were conducted
or not.
Types of participants
Eligible participants included children and adults living
with HIV. Reviews were excluded if the primary sample
of interest included more than 50% of the population
who were not HIV positive. Although PLHIV were the
target participants in this review, information obtained
from health professionals and primary caregivers were
considered if it pertained to perceptions of barriers and
facilitators to linkage, adherence and retention in care
for PLHIV. Children and youth referred to PLHIV up to
the age of 24 years. Where included reviews specifically
referred to the age group as youth, older than 12 years,
we reported it as youth in our findings.
Types of issues
Eligible reviews addressed linkage to ART, adherence
to treatment and retention in care of persons testing
positive for HIV. Enrolment in antiretroviral therapy
(ART) care following a positive HIV test is referred to as
linkage to care in this overview. While no specific criter-
ion exists with regard to linkage to care, it has been pre-
viously defined as one visit or more during the first 6
months of receiving a positive diagnosis and the initi-
ation of antiretroviral treatment [31]. Adherence to ART
Fig. 1 Steps of the overview using mega-aggregation framework synthesis of qualitative systematic reviews
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refers to the extent to which a person who is HIV posi-
tive follows their prescribed regimen of care and takes
their medication as they should [33, 34]. Since the intro-
duction of ART, there has been a decline in AIDS-
related deaths and life expectancy for those infected with
HIV has increased [15]. Viral suppression is optimal
when PLHIV have an adherence rate of 95% or more
[16]. Retention in HIV care is described as constant at-
tainment of the suitable medical care that includes at-
tending follow-up appointments, medical tests or any
other activity that was suggested by a healthcare practi-
tioner to be maintained [35]. Reviews addressing the is-
sues related to prevention including pre-exposure
prophylaxis (PREP) and pre-ART care were excluded
from this overview.
Types of contexts
Reviews synthesising information from high-, middle-
and low-income countries were included in this over-
view. The geographic settings included rural and urban
across all global regions.
Types of outcomes
The review-level outcomes of interest were self-
reported barriers and facilitators to linkage to ART, ad-
herence to ART and retention in care. Outcomes that
were measured and reported using statistical associations
between various factors and linkage, adherence and re-
tention in care were not included.
Step 4: conduct searching and screening
A comprehensive search for systematic reviews up to 25
July 2018 was conducted in the Cochrane Library (spe-
cifically the CDSR and DARE), The Campbell Library,
MEDLINE via PubMed, SCOPUS and CINAHL
EBSCHOhost. PROSPERO was also checked for ongoing
systematic reviews. Experts in the field were contacted
and reference lists of included reviews were checked to
identify further potential reviews for inclusion. An add-
itional search on Google Scholar was conducted to
search for reviews not contained within the databases.
Key terms included in the search strategy were ‘HIV’,
‘linkage’, ‘adherence’, ‘retention in care’, ‘ART’, ‘qualita-
tive’ and ‘systematic reviews’. Search terms were modi-
fied appropriately for the various databases. Detailed
search strategies for all databases are reported in Add-
itional file 1. No language, geographic or time restric-
tions were used in the search. Two authors (LH and
AR), using Covidence [38], independently and in dupli-
cate screened titles and abstracts of the records retrieved
by the electronic searches for relevance; based on the
participant characteristics, issues addressed, study design
and outcomes. Full texts were retrieved for all potentially
eligible reviews and were screened independently and in
duplicate by two authors (LH and AR). Disagreements
were recorded in Covidence [38], and these were
resolved by consensus or through discussion with a third
author (IEW). Reviews were categorised as included, on-
going, awaiting assessment or excluded with reasons.
Step 5: conduct quality appraisal of the included studies
Included systematic reviews were subjected to quality
appraisal by the first author (LH) and second author
(AR) independently and in duplicate. Discrepancies were
resolved through discussion. Risk of bias was assessed
using an amended version of the Joanna Briggs Institute
Critical Appraisal Checklist for Systematic Reviews [39]
(JBI-SR-Checklist) (Table 1). The JBI-SR-Checklist con-
tains 11 guidance questions for the appraisal of system-
atic reviews. As this tool can be used for quantitative or
qualitative reviews, we only considered those guidance
questions that were appropriate for the assessment of
qualitative reviews. Therefore, we omitted the question
‘Was the likelihood of publication bias assessed?’, as this
was not applicable to this overview. Furthermore, we
added a question that we thought was important to con-
sider, namely ‘Was the screening and study selection ap-
propriate?’. Each question was answered as ‘yes’, ‘no’ or
‘unclear’. The critical appraisal guide [39] provides key
considerations for review authors when conducting ap-
praisal. For the purpose of this overview, specific deci-
sion rules from the original JBI-SR-Checklist manual
[39] were revised (Additional file 2) and clarified for
making judgements about risk of bias, in order to ensure
consistency between reviewers and across included re-
views. No study was excluded based on the results of the
quality assessment but rather it was used to identify
weaknesses in study methodologies and to strengthen
Table 1 Revised Joanna Briggs Institute (JBI) 11-item checklist
for systematic reviews
Revised JBI systematic review checklist items [39]
1. Is the review question clearly and explicitly stated?*
2. Were the inclusion criteria appropriate for the review question?*
3. Was the search strategy appropriate?*
4. Were the sources and resources used to search for studies
adequate?*
5. Was the screening and study selection appropriate?*
6. Were the criteria for appraising studies appropriate?*
7. Was critical appraisal conducted by two or more reviewers
independently?*
8. Were there methods to minimise errors in data extraction?*
9. Were the methods used to combine studies appropriate?*
10. Were recommendations for policy and/or practice supported by the
reported data?
11. Were the specific directives for new research appropriate?
*Items used in the calculation of quality assessment score
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and inform the interpretation of the results of the sys-
tematic reviews.
We assessed the overall quality of systematic reviews
as either low, medium or high, by considering items 1–
9. Although the area of quality assessment in QES is still
being debated in the field and the philosophical under-
pinning and epistemological reasoning behind conduct-
ing or not conducting quality assessment are unique to
the rationale and question of the review authors [25], we
included these in our assessment. We assessed items 10
and 11, but excluded them from our calculation for level
of quality, as these questions do not relate to risk of bias,
but rather to the validity of the findings, as stated in the
JBI-SR-Checklist manual [39]. Additional File 2 explains
how we made decisions about the overall quality of in-
cluded reviews.
Step 6: data extraction and categorisation
The data extraction took place in two phases: (1) data
extraction of characteristics of included studies and (2)
data extraction of barriers and facilitators for data
synthesis.
Data extraction of characteristics of included reviews
and their primary studies
Data was extracted by the first author (LH) and
checked and validated by a second author (AR) and
third author (IEW) using a pre-specified piloted data
extraction form in Microsoft Excel (Additional file 3).
The extracted data included information on databases
searched, date of the last search, what the reviews au-
thors searched for and what they found in terms of
types of studies, types of participants, the issue of
interest, the setting or context, barriers and facilita-
tors related to issues of interest. Details of critical ap-
praisal tools, theoretical frameworks or models,
methods of synthesis and limitations were also ex-
tracted. Information about the primary studies in the
included systematic reviews were extracted, and these
included the author names, year of publication, coun-
tries included and types of participants from primary
source studies relevant to the overview, in order to
describe the overlap of primary studies in systematic
reviews included in the overview. Review authors
were contacted for the full text papers if they were
not available to the review team. Discrepancies in
data extraction were discussed and once consensus
was reached, the second phase commenced.
Data extraction of barriers and facilitators for data
synthesis
The first author (LH) read the systematic reviews sev-
eral times to become more familiar with the findings
and recommendations made by the review authors. Fol-
lowing this, LH extracted barriers and facilitators verba-
tim into Excel for each review and categorised them
according to the pre-specified dimensions of the Kauf-
man HIV Behaviour Change Model [23]. The review-
level findings had to be supported by evidence such as
references to the primary studies, direct quotes, visual or
text evidence from the primary study, visual representa-
tions such as tables and figures with references to the
primary studies, to be included in the extraction. The
second author (AR) and third author (IEW) checked and
validated the extracted barriers and facilitators in the
Excel spreadsheet, and where discrepancies were raised,
consensus was reached through discussion.
Step 7: present and synthesise the findings
The principles of meta-aggregation and framework syn-
thesis were integrated to design and apply the novel ap-
proach of ‘mega-aggregative framework synthesis’ to this
overview. Meta-aggregation is a method of data synthesis
used in QES and focuses on aggregating primary-level
findings into categories and then further aggregating
those categories into synthetic statements that may be
used for policy and practice without losing the critical
interpretive value of the qualitative findings [21]. Mega-
aggregation, which is a review-level higher, is a method
of qualitative synthesis and aims to aggregate third-order
review-level data into higher-order themes, called
fourth-order themes with the purpose of identifying the
scope of the available review-level evidence and make
recommendations for research, policy and practice. In
keeping with recent guidelines in selection of approaches
for meta-synthesis and the large number of existing re-
views available on the topic of this overview, a frame-
work was applied to the mega-aggregative approach.
Using a broad framework in mega-aggregation is useful
for categorising the themes and findings of systematic
review papers which, although may have included vari-
ous qualitative designs, consider the same objective or
issue and outcomes.
As with mega-ethnography [8], this type of synthesis
considers first-order constructs (from the person),
second-order constructs (interpretations of the author
in a primary study), third-order constructs (findings
in a systematic review) and fourth-order constructs
(findings in an overview of reviews). Using the ex-
tracted third-order constructs in the framework di-
mensions, we then discussed and created fourth-order
themes. The third-order concepts were coded into
fourth-order concepts further categorised into the
appropriate framework dimensions for each of the
outcomes. We were then able to review the tables
and identify evidence gaps and lines of action to in-
form future research, policy and practice. The overall
number of findings contributing to each of the
fourth-order themes of the overview was examined,
and the most emergent (meaning the fourth-order
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themes with the most findings) barriers and facilita-
tors, across included systematic reviews, were dis-
cussed in the manuscript. Evidence of all findings are
presented in in-text tables and within the additional
files of the manuscript. Additionally, we identified the
evidence gaps and explored the gaps by country in-
come classification, population group and fourth-
order themes. Further detail on the application of
mega-aggregation framework synthesis to this over-
view is provided in Additional file 4.
Step 8: transparent reporting
This overview used guidance from the Johanna
Briggs Institute Methodology for Umbrella Reviews
[39] and the PRISMA Extension for Scoping Re-
views Checklist (PRISMA-ScR) [40] (Additional file
5). The protocol [17] pertaining to this overview
was registered on PROSPERO (CRD42017078155)
on 17 December 2017. Differences between the
protocol and the manuscript are reported in Add-
itional file 6.
Results
Overview of the search results
The database search resulted in 2762 article citations
and an additional seven reviews were identified
through other sources (two within the reference lists
of included reviews and five through other readings).
After the removal of duplicates, 1921 citations were
imported into Covidence and the title and abstracts
were screened, resulting in 78 retrieved for full text
review. Thirty-nine reviews were excluded (Additional
file 7), most reviews did not fit the criteria of a sys-
tematic review (n = 10), did not contain qualitative
primary studies or data (n = 4) or did not include the
target population group (n = 1). We were unable to
obtain the full texts for two reviews and are waiting
on information from one author and have classified
these three reviews as ‘awaiting assessment’. Three
ongoing reviews or protocols were found in our
search (Additional file 7). We included 33 [41–73]
systematic reviews in this overview. Figure 2 describes
the flow of reviews through the different stages of
this overview using the PRISMA flow diagram [74].
Fig. 2 PRISMA flowchart
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Description of the systematic reviews included in the
overview
Included systematic reviews were published between
2006 to June 2018, peaking at 6 publications in 2018
(Fig. 3).
The included reviews (N = 33) synthesised primary studies
that were conducted in both high-income countries and low-
and middle-income countries with a large concentration of
included primary studies being conducted in sub-Saharan
Africa (Fig. 4). No reviews written in languages other than
English were found.
Self-reported barriers and facilitators of 1,156,540 PLHIV
(children and youth, and adults) are included in this over-
view. Some reviews included high-risk populations, such as
pregnant and postpartum women, children and adolescents,
commercial sex workers, men who have sex with men, trans-
gender persons, prisoners, intravenous drug users and for-
eign nationals. Two reviews on children and adolescents
included data from caregivers. Table 2 summarises the char-
acteristics of included studies.
We applied the conceptual definitions of the outcomes
as per the overview protocol and we found that 13 re-
views addressed the outcome of linkage to ART, 29 ad-
dressed the outcome of adherence to ART and 11
addressed the outcome of retention in care (see Fig. 2).
The method of synthesis of the reviews varied and in-
cluded thematic analysis, thematic content analysis, con-
tent analysis, narrative synthesis, meta-synthesis and
meta-aggregation. Details of data are extracted, and crit-
ical appraisal of each included review is available in Add-
itional file 8.
Due to the different ways of reporting results in the in-
cluded reviews, we discerned between two population
groups in terms of age, children and youth, and adults.
Overlap between included systematic reviews
We found overlap in the qualitative, quantitative and
mixed methods primary studies included within the 33
systematic reviews (Additional file 9). Review authors
used varying definitions of linkage to ART, adherence to
ART and retention in care when considering studies for
inclusion. One author may have used a primary study to
synthesise evidence on linkage to ART and another au-
thor may have used the same study to synthesis evidence
on adherence to ART. The primary studies within the
systematic reviews were published between and 1995
and 2017. Of the 1153 primary studies in the systematic
reviews, 826 were unique studies, of which 616 were in-
cluded in only one review. We found that 139 of the
studies were included in two reviews, forty-seven in
three reviews, fourteen in four reviews, three in five, four
in six, and one study was included in seven reviews and
another across eight reviews.
We explored whether there was overlap in the search
dates between the included reviews and found that most
reviews searched between 2000 and 2013 with an aver-
age search period covering 13 years (Fig. 5). Eight studies
[44, 45, 56, 58, 60, 65, 67, 71] conducted comprehensive
searches up to a year before publication. One review
[41], conducted as part of an online postgraduate degree
programme, had very short search period of 6 months.
We found considerable overlap in the search dates of in-
cluded systematic reviews.
Quality assessment of systematic reviews included in the
review
The methodological quality of the included systematic
reviews varied across reviews. Details of the justifications
for quality judgements are reported in Additional file 8.
Fig. 3 Number of included systematic reviews by publication year
Hendricks et al. Systematic Reviews           (2021) 10:54 Page 8 of 28
All but five reviews had clear research questions. Key
methodological aspects that were appraised as good qual-
ity were the relevance of recommendations for policy, hav-
ing a clear research question and relevant directives for
future research. The key aspects that were assessed as
poor for the included reviews were the sources used to
search and the inclusion criteria of the reviews. Some re-
views did not clearly report items, and as we were thus
unable to make a judgement, we assessed them as ‘un-
clear’. Items concerning if the ‘process of data extraction
was appropriate’ and if the ‘critical appraisal was con-
ducted by two or more authors’ were mostly identified as
‘unclear’ across included reviews. We identified 110
(30.3%) items out a possible 363 as ‘unclear’, 70 (19.3%)
items as ‘no’ and 183 (50.4%) of items as ‘yes’. Two reviews
[62, 65] were rated as high quality, six reviews [41, 43, 46,
55, 61, 67] were rated as medium quality and 25 reviews
[42, 44, 45, 47–54, 56–60, 63, 66, 68–73, 75] were rated as
low quality (Table 3).
Data categorisation: what is the available review-level
evidence on barriers and facilitators to linkage,
adherence, and retention in care?
We found 544 unique third-order concepts from the in-
cluded systematic reviews and to retain the essence of
the review authors’ interpretations, we extracted con-
cepts verbatim. We then categorised and aggregated the
evidence into the predetermined framework, namely,
Kaufman’s Behaviour Change Model of HIV [23].
Barriers and facilitators to linkage to ART
Barriers and facilitators to linkage to ART were found
on all levels of the Kaufman framework (Additional file
10) and contributed to the synthesis of the barriers and
facilitators to linkage to ART. One low-quality review
[73] contributed to the findings on linkage for children.
For adults, findings for linkage, were aggregated from
one high-quality review [65], three medium-quality re-
view [43, 46, 55], and eleven low-quality reviews [42, 44,
45, 49, 50, 53, 54, 58, 60, 64, 66].
On the individual level, participants reported bar-
riers linked to sociodemographic factors (5 findings),
such as being younger, whether the participant’s oc-
cupation was considered socially acceptable, gender,
and not having identification documents in order to
enrol in care services. Barriers related to patient fears
(9 findings) were the emergent themes. PLHIV
expressed fears of the consequences of disclosure,
such as job loss, stigma and social isolation, fears of
being on lifelong treatment and the negative side
effects of ART. PLHIV reported experiencing psycho-
logical distress and emotional reactions (9 findings)
and some were shocked at the news of their positive
status, unsure about how they had contracted the dis-
ease, and the possibility of infidelity in their relation-
ships. Feelings of hopelessness and depression were a
recurring theme, with women questioning their self-
esteem as wives and mothers. For children, two find-
ings of barriers to linkage included negative emotions
and self-perception.
Fig. 4 Distribution of countries included in the included systematic reviews (N = 33)
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PLHIV doubted their ability to adhere and commit to
lifelong treatment and care. Themes for the facilitators
of linkage to ART on the individual level included phys-
ical health (6 findings) and barriers regarding physical
health (8 findings). In the context of participants’ psy-
chological distress, some reviews found that participants
could no longer ignore the physical symptoms of the dis-
ease or their declining health, while others found that al-
though they tested positive for HIV, they were
asymptomatic, and therefore delayed care. The desire to
care for family, protect unborn children from the trans-
mission of HIV, as well as the desire for future marriage
and children facilitated children’s linkage.
On the interpersonal level, relationships in the house-
hold emerged as an important theme, both as barriers (7
findings for adults and 1 finding for children) and facili-
tators (3 findings for adults and 1 finding for children).
PLHIV reported conflicts in the household, threats of
domestic violence and abandonment, and the lack of au-
tonomy for women, as barriers to linkage to ART. In
contrast, supportive partners and families with
mutuality-fostering relationships involving empathy fa-
cilitated linkage.
On the community level, the main barrier expressed
was stigma and discrimination (4 findings), which is
linked to community narratives around masculinity, HIV
as witchcraft, and hospitals as places of death. Children
reported unsupportive teachers (1 finding) as a barrier
to linkage. Facilitators reported included peer support
and support groups (6 findings) which served as a proxy
for family support when it was lacking. One finding for
adults included community beliefs and practices as a
barrier with negative beliefs about ART, detrimental
gender norms, and a preference for traditional healers
and medicines.
At the institutional level, barriers such as stigma expe-
rienced at health care facilities (7 findings), service deliv-
ery (24 findings), which includes overcrowding, long
queues, high staff turnovers, inconvenient client times,
poor resources and participants’ experiences with limited
medication availability as well as their experiences of
HIV testing were reported. Four findings were related to
barriers of institutional models of care. PLHIV identified
gaps in the ART cascade referral process, particularly for
women who test positive during their antenatal care
(ANC) and are not followed-up postpartum, as well as
lack of integrated services. PLHIV perceived health care
models such as home visiting, as a barrier, as it might
contribute to involuntary disclosure. There were four-
teen findings for facilitators in the theme models of care,
including offering population-specific services for
adolescents, the integration of HIV care within ANC,
offering mental health assessments and providing multi-
level, multi-pronged approaches to care. The facilitators
for the theme service delivery (2 findings) included
PLHIV having positive experiences of HIV testing and
encountering a clinic staff member who welcomed
people into the clinic. Counselling practices and princi-
ples (6 findings) that respected the place of traditional
medicine, incorporated the traditional beliefs of people,
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and that provided in-depth counselling before and after
HIV testing were reported as facilitators on the institu-
tional level. Children reported lack of privacy experi-
ences at the clinic, the physical environment at the clinic
and high staff turnover as barriers to linkage (1 finding).
On the structural level, reported barriers included the
financial cost of care (2 findings), healthcare policies (3
findings), income and food security (4 findings), trans-
port and distance to the clinic (4 findings) and one find-
ing for living conditions and context. Facilitators
included income and food security (1 finding), and
transport and distance to clinic (2 findings), which in-
cludes having an escort to the clinic.
Only one high-quality review [65] was found that ad-
dressed linkage to care for HIV-positive adults. One
theme was included from the high-quality review,
namely, medication as a reminder of HIV status, within
the individual level of the framework.
Barriers and facilitators to adherence to ART
Findings on barriers and facilitators to adherence to
ART, and reviews reporting on these are summarised in
Additional file 11. For children, one high-quality review
[65], one medium-quality review [41] and two low-
quality reviews [68, 73] contributed to the aggregation of
findings. For adults, two high-quality reviews [62, 65],
four medium-quality reviews [43, 55, 61, 67] and twenty
low-quality reviews [44, 47, 48, 50–56, 58–68, 70–73]
contributed to the findings for adherence to ART.
On the individual level, emerging themes related to
barriers to adherence were linked to medication (19
findings), sociodemographic factors (18 findings) and
fears (12 findings). Reviews reported medication charac-
teristics, negative side effects, pill burden and regimen,
travelling away from home and lack of privacy as bar-
riers, and the use of reminders, simpler medication regi-
mens as facilitators, within the medication theme.
Several reviews synthesised findings on the self-reported
sociodemographic characteristics such as levels of educa-
tion, age and gender. In some cases, a woman’s positive
HIV status was considered a result of her husband’s infi-
delity and reduced the risk of stigmatisation when dis-
closing her status. In other cases when women were
seen taking their medication they were stigmatised as
Fig. 5 Overlap between search dates of included systematic reviews (N = 33)
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hypersexual and were discriminated against. Other re-
ported barriers were grouped under the themes psycho-
logical distress and emotions (15 findings) and fears (12
findings). Fears were related to the medication toxicities,
side effects, unintentional disclosure, that the treatment
would harm a pregnant woman’s unborn child and the
fears that ART leads to impotency, infertility, and the
impossibility of sexual activity.
The theme of coping strategies (12 findings) and de-
sires (7 findings) were identified as facilitators to miti-
gate fears, anticipated stigma and negative side effects of
ART. Coping strategies included being aware of personal
strengths and weakness, learning to manage the HIV
diagnosis and interpreting physical signs of the body,
drinking liquids, resting and adopting a resilient and
positive attitude. People desired to be healthy to care for
their families and to maintain their appearance to keep
their status a secret. Knowledge and understanding was
identified both as a barrier (6 findings), such as receiving
conflicting messages from community members, pro-
viders, peers and the media; and as a facilitator (7 find-
ings) such as, understanding the need for compliance.
On the interpersonal level, peoples’ relationships
within the household emerged as a barrier (15 findings)
and facilitator (7 findings) to adherence. Family involve-
ment and emotional, material, and social support were
important factors to PLHIV. Other barriers such as pun-
ishment for lack of adherence for children, negative fam-
ily reactions to disclosure, enacted stigma by family
members and lack of autonomy in relationships made it
difficult for people to adhere.
Community level barriers were related to community
beliefs and practices (6 findings) such as strong negative
community beliefs about HIV and bypassing of clinics
and hospitals for traditional healers. Peers and support
groups (6 findings) played a mitigating role and helped
participants adjust to their new daily routine. Financial
and emotional support also facilitated adherence.
The two emergent themes identified at the institu-
tional level of the framework were service delivery
(27 findings), which was reported as a barrier; and
models of care (15 findings), which was reported as a
facilitator. People who may have had the intention of
adhering to ART were discouraged by the difficulties
of making a scheduled appointment and the long
waiting times at the clinic when they did seek care.
Negative experiences at the clinic when collecting the
refills of medication included the lack of privacy,
overcrowding and stigma experienced within the
clinic by other patients, community members and
staff. People reported spending up to a day waiting
to see a health care worker and were presented with
additional barriers such as drug stock-outs or limits
on the amount of medication that could be
dispensed at a time. Models of care, such as inte-
grated mental health care, integrated antenatal care
(ANC) and HIV care, and specialised services for ad-
olescents, with highly skilled and trained healthcare
workers,
The structural-level themes identified for barriers to
ART adherence included the financial cost of ART,
healthcare policies, and income and food security,
each of which had three findings. PLHIV reported
that food insecurity and no access to liquids pre-
vented them from taking their medication. PLHIV felt
discouraged by their lack of understanding of health-
care policies and some reported the barrier of access
laws at health care facilities that sent patients to their
birthplace to seek care. Policies directed at specific
populations with criminalising threats for transgender
persons, commercial sex workers, drug users and de-
portation threats for immigrants were reported as
barriers. Even with the advent of free ART, the indir-
ect cost of ART is still high in low-income settings
with participants expressing the challenge of travelling
to clinics in rural areas, the affordability of safe, reli-
able transport and the indirect cost of childcare when
visiting the clinic in order to collect medications. Fa-
cilitators at the structural level included financial re-
lief for care (5 findings) and income and food
security (2 findings), which included the provision of
grants for food supplementation and travel
reimbursement.
One high-quality review [65] found that children re-
ported their daily routines and lifestyle, desires to have
their lives pre-ART normalised, fears of stigma, fears of
the related effects of ART as well as actual negative ef-
fects experienced, non-acceptance of HIV status, con-
flicting messages regarding ART, forgetting or
misplacing medication, medication characteristics, pill
burden, feeling better, unsupportive family relationships
and social isolation as barriers to their medication ad-
herence. No facilitators of adherence to ART for chil-
dren were reported in the high-quality review. Review
findings from two high-quality reviews found that adults
reported their beliefs about ART, coping strategies, daily
routines, desires, fears, HIV acceptance and non-
acceptance, knowledge and understanding of ART,
medication factors, physical health, psychological dis-
tress, age and competing life interests on the individual
level. Relationships in the household on the interper-
sonal level of the framework; peer and social support
groups on the community level; perceptions and engage-
ments of health care workers, integrated models of care,
male only services, health care workers’ recommenda-
tions, service delivery, financial costs and health care
policies on the institutional level; and food insecurity,
housing and income as structural factors were self-
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reported by people as barriers and facilitators of adher-
ence to ART.
Barriers and facilitators to retention in care
Ten reviews contributed to the findings for retention in
care, and the barriers and facilitators as reported in the
reviews, by country income level and quality rating, are
presented in Additional file 12. Five low-quality reviews
[50, 52, 58, 66, 73] reported on the barriers and facilita-
tors of retention in care for children. Findings for adults
were found in seven low-quality reviews [42, 50, 52, 56–
58, 66] and two medium-quality reviews [46, 55]. No
medium- or high-quality reviews were found for chil-
dren and no high-quality studies were found for the
PLHIV self-reported barriers and facilitators of reten-
tion in care.
The prominent themes on the individual level were the
barriers of sociodemographic factors (5 findings), such as
issues around gender, and concerns about not have regis-
tered identification documents to access care due to either
immigrant status or being transgender; the themes of fears
(4 findings); and psychological distress and emotional re-
actions (7 findings). PLHIV reported experiencing mental
fatigue from being retained in care and experiencing psy-
chological suffering as an adult with HIV, which included
feeling angry, feeling like they have lost control of their
lives and feelings of depression and hopelessness.
On the interpersonal level, emergent themes included
the barriers (5 findings) and facilitators (3 findings) of
disclosure. Disclosure was reported as a barrier either in
cases when participants chose not to disclose, and this
resulted in sporadic care within health care systems, or
due to post-disclosure stigma. Family members who
were supportive and relationships in the household (6
findings) were reported as facilitators of retention in
care. Partners who were emotionally supportive and en-
couraged healthy living were considered facilitators of
retention in care. In other instances, partners who were
not involved in care were considered as barriers, with re-
views reporting that women did not have decision-
making power in some contexts, and this denied them
the opportunity to seek care.
The community level had two emergent themes with
one finding each. These included the theme of commu-
nity beliefs and practices and the theme of peers and
support groups, which was also reported as facilitators
with six key findings. Facilitator findings included having
a treatment companion, identifying a confidante, attend-
ing support groups and enlisting the help of supervisors
and teachers to facilitate retention in care.
For retention in care, many themes that related to the
institutional level were reported. Themes included ser-
vice delivery (20 findings) and models of care (17 find-
ings), followed by stigma in health care and engagement
(7 findings) and engagement with health care workers (6
findings). Service delivery barriers included long waiting
times and subsequent short consultations with health
care workers, drug and test stock outs, lack of privacy,
laboratory challenges, negative experiences of testing for
HIV, the physical clinic environment and the failure of
the health care facility to keep up with rapidly changing
treatment protocols. PLHIV reported same-day appoint-
ments between services offerings at the clinic, their ex-
periences of HIV testing and the provision of disability
accommodations to be facilitators of service delivery (5
findings). The facilitators of models of care (9 findings)
included integrated care to reduce patient burden, the
treatment of depression and anxiety related to diagnosis,
offering male-friendly services without needing to access
care through partners’ ANC services and home visiting
or mobile care units.
Structural-level barriers were emergent for health care
policies (4 findings), financial costs of care (2 findings),
transport and distance to clinic (2 findings), and one
finding each for income and food security, and living
condition and context. PLHIV reported the cost of at-
tending care even while ART was universally free and
accessible as a barrier to engaging in care. Indirect costs
included the loss of wages when attending the clinic,
transportation costs, childcare costs and the possible loss
of grants due to their HIV-positive diagnosis. Only one
facilitator of having a higher income was reported at the
structural level.
No high-quality reviews were found for self-reported
barriers and facilitators of retention in care for children
or adults.
Synthesis of findings
Identifying themes and subthemes
We reclassified the third-order concepts into 45 fourth-
order themes within the five levels of the Kaufman [23]
HIV behaviour change model and summarised the
themes of included reviews linked to the outcomes
(Additional file 13). For the individual level, we found 19
themes; for the interpersonal level, five themes; for the
community level, six themes; for the institutional level,
eight themes; and for the structural level, we found six
themes (Fig. 6).
What are the knowledge gaps in the available review-level
evidence about linkage to care?
Review-level evidence (Additional file 9) on the barriers
and facilitators to linkage to ART for children is sparse,
with a single review reporting on children and adoles-
cents in low- and middle-income countries. A low-
quality review identified the main barriers for children in
both low- and middle-income countries were categorised
into the interpersonal and institutional level of the HIV
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behaviour change model. Review-level evidence is lack-
ing for the psychological distress and emotional reac-
tions experienced by children and adults when learning
about their positive status and possible mode of trans-
mission, whether through unprotected sex or vertical
transmission. Furthermore, the mental health of PLHIV
as they engage in the continuum of care is underrepre-
sented in the literature. Review-level evidence of the fa-
cilitators of linkage are under-reported, as are children’s
perceptions of and engagement with health care
workers. No high-quality reviews reporting on children’s
self-reported barriers and facilitators to linkage were
found. For adults, much of the review-level evidence has
synthesised the barriers of linkage to ART rather than
the facilitators. With only one high-quality review, there
is a need for more high-quality reviews on the facilitat-
ing effect of community beliefs and practices, internal
beliefs and the role of peers and support groups for link-
age to treatment for ART. Additionally, there is lack of
evidence on the coping strategies employed by children
and adults to facilitate linkage. There is a need for high-
quality evidence on environmental factors and the social
determinants of health on people’s linkage to ART.
What are the knowledge gaps in the available review-level
evidence about adherence to treatment?
There is minimal review-level evidence for children
when compared to the existing evidence of adherence to
ART in adult populations (Additional file 10). We found
only one high-quality review for children and two high-
quality reviews for adults. However, when comparing the
methodological quality of reviews, there is a large body
of low-quality reviews, with most reviews being con-
ducted on populations from low-income countries. Indi-
vidual beliefs, desires, coping strategies and fears are
addressed in the literature for adults but not adequately
for children. No review-level evidence was available on
the relationships within the household in low- and
middle-income countries for children. There is a large
quantity of evidence on the barriers of the characteristics
of the medication, the side effects, the psychological dis-
tress and emotional reactions and the effects of service
delivery but a gap exists in the evidence of the facilita-
tors that can mitigate these barriers in adults. Evidence
in adults is lacking on the role of environmental factors,
personal beliefs, cultural practices and traditional com-
munity beliefs on adherence to ART. Further exploration
on the self-reported experiences of psychological distress
and engagement with peers in the context of stigma is
needed.
What are the knowledge gaps in the available review-level
evidence about retention in care?
The existing evidence for retention in care is sparse
(Additional file 11), and no high-quality reviews were
found. The focus of synthesis from the included studies
Fig. 6 Summary of fourth-order themes by levels of the HIV behaviour change model
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has primarily been conducted in adult populations in
low- and middle-income countries. Five low-quality re-
views and one medium-quality review addressed the out-
come of retention in care among children and no high-
quality reviews were found. In children, caregivers are
seen as the primary caregivers and gatekeepers for man-
agement of a positive HIV diagnosis, but this is not dis-
played in the existing evidence, as there is a lack of
research that is available. Additionally, the role of care-
givers in adult populations was not available in the in-
cluded reviews. In low- and middle-income countries,
complexities regarding the co-existence of traditional
medicine and scientific-based medicine are briefly men-
tioned, but not explored, in review-level evidence. Adult
population self-reports of family and social relationships
are synthesised in low- and middle-income countries as
well as high-income countries; however, there is no
review-level evidence for children. There is a need for
more review-level evidence on the impact of the envir-
onment and structural community on retention in care.
No high-quality reviews were found for PLHIV reporting
barriers and facilitators to retention in care.
Lines of action and recommendations
Several of the individual, interpersonal, health system
and structural-level factors identified in this overview
are well known and have been identified in previous lit-
erature [35, 75]. We identified key areas and population
groups which were under-represented in the review lit-
erature and where syntheses of primary research may be
needed to understand these factors better.
First, individual-level factors such as peoples’ fears,
psychological distress, and beliefs about ART, and con-
flicting beliefs between cultural practices and medicine,
were frequently reported; there was however little to no
emphasis in qualitative reviews on the facilitators to
mitigate these barriers in children or adult populations.
Second, interpersonal factors such as the dynamics of
relationships within the household, and the fears, anxie-
ties, experiences of disclosure and support from peers
and support groups were identified both as facilitators
and barriers to care; however, details about the complex
relationship of these factors needs further exploration.
Third, models of care and service delivery practices
adopted by health care centres were prominent themes:
with long waiting times, the risk of unintentional dis-
closure and the negative treatment by health care
workers reported as barriers. Skilled health care workers,
targeted services for men and youth, and integration of
care as facilitating care were identified. Further explor-
ation of not only the healthcare workers, but also the
clinic facility, both as a physical space and beliefs about
the clinic, is needed.
Fourth, structural-level themes included transportation
to the clinic, poverty and low-income levels linked to the
lack of food. Emerging issues related to the sensorial ex-
perience of adherence, the physical environment and
community structure has yet to be explored in qualita-
tive systematic reviews related to HIV.
Fifth, although there is progress to achieving the
90-90-90 targets, this study identified many challenges
experienced by PLHIV and the themes of self-
reported barriers provide a rich overview of the inter-
woven complexities of the lives of PLHIV. Recent lit-
erature linking barriers and facilitators of linkage,
adherence and retention in care to priority solutions
propose differentiated service delivery, client-centred
care, safe spaces for HIV treatment and care, adoles-
cent friendly services, family centred services and ad-
vocacy for human rights, among others, to best serve
the needs of PLHIV and reduce the burden on the
health care systems. Investigation and scale up of in-
terventions for PLHIV to promote their adherence
must be intensified and barriers and facilitators even
beyond the realm of interventions proposed including
reminder devices, pill box organisers, reduced toxicity,
mental health screening and fixed dosed combinations
must be explored.
Sixth, this overview identifies the need for qualitative
exploration of the agency of the material environment
encountered by PLHIV, not included in existing reviews
or in intervention research and will make valuable con-
tributions to the body of knowledge. The exploration of
agency goes beyond the identification and description of
themes to exploring the understanding of the meaning
ascribed to materials such as agency of the human body
of PLHIV, the agency of matter such as money, trans-
port vehicle, clinic environments, food, community
structural factors and living spaces, context and agency
of medications.
Lastly, this study identified the need for more high-
quality review-level evidence for key populations, specif-
ically, children and youth with perinatal HIV infections,
as they were underrepresented in the data. Most in-
cluded reviews were assessed as having low quality. Fu-
ture qualitative systematic reviews in the field of HIV
linkage, adherence and retention in care should follow a
rigorous approach to minimise the risk of bias.
Discussion
This study described the innovation and first application
of the mega-aggregative framework synthesis approach
to explore self-reported barriers and facilitators of care
in PLHIV as reported in existing qualitative systematic
reviews. The purpose of mega-aggregation framework
synthesis is to provide an overview of review-level find-
ings to produce lines of action which leads to
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recommendations. As the number of qualitative reviews
increases exponentially [18, 19] and the risk of review
duplication in HIV research is high, we considered it
valuable to appraise and synthesise the existing evidence.
This novel application was conducted on real review-
level data which identified 33 systematic reviews from
low-, middle- and high-income countries, reporting on
linkage to ART, adherence to ART and retention in HIV
care, for all populations, across all settings, from 1990
up to July 2018. The protocol was predefined and the
overview conducted and reported in a transparent way,
with all evidence, data extraction, critical appraisal, justi-
fications for decisions, clear decision guides and data
presented in additional files alongside the manuscript.
The search was comprehensive, and data extraction,
screening and critical appraisal was conducted independ-
ently by two authors.
Mega-aggregation framework synthesis for qualitative
reviews has been shown to be a reliable and efficient
method of synthesis when aiming to identify the quality
and scope of available evidence. Researchers are encour-
aged to use and build on the method as overviews be-
come more prominent in qualitative systematic review
literature. Our overview found that the main self-
reported barriers and facilitators to linkage, adherence
and retention such as psychosocial characteristics of
PLHIV such as desires, fears, experiences of HIV and
ART, coping strategies and mental health intersected
with other factors on the interpersonal, community, in-
stitutional and structural level. PLHIV identified stigma
and lack of social support, alongside health care services
that were not sensitive to their individual needs as bar-
riers to adherence and retention in care. In low-income
countries, structural, community and institutional fac-
tors were reported frequently, and in high-income coun-
tries, individual-level barriers such as fear of medication
side effects were more apparent. Although the overall
quality of the reviews was low, the findings of this over-
view provide sufficient evidence to assist with the identi-
fication of knowledge gaps in the literature and clear
lines of action for research, policy and practice. To
understand the experiences of PLHIV when considering
committing to lifelong treatment, the potential post-
disclosure life changes and the side effects, juxtaposed
with their beliefs about medication and diseases, it is im-
portant to consider all the factors on the individual,
interpersonal, community, institutional and structural
factors that influence their decision-making and actions.
Practitioners working in health care cannot treat patients
only for their diagnosis of HIV but must provide holistic
care and be aware of the barriers and facilitators that
these patients may be experiencing, from the patients’
perspectives. Themes that were found varied across
stages of the HIV cascade, and the reasons why PLHIV
chose to adhere could be different to the reasons why
they chose to engage in care or attend the clinic. The ex-
periences of one patient may not be the experience of
another and should be dealt with a case-by case manner
within the contextual circumstance of the patient. The
healthcare policies have been reported as not easily
understood and methods of dissemination and education
need to be considered for information uptake in com-
munities. Exploration into the agency of the material
spaces occupied and material items in the spaces of
PLHIV will provide further understanding on the com-
plex interplay of barriers and facilitators, especially in
low- and middle-income countries. Community engage-
ment workers can use their platforms to create open dia-
logues about HIV, the negative beliefs and stigmas, the
dissemination of information on services that are pro-
vided in the communities and to promote the positive
effects of staying adherent to ART for people infected
with HIV. The findings of this overview provide re-
searchers and practitioners with a broad overview of the
existing evidence and are useful in the development
of new research questions to respond to evidence
gaps identified. It is known that the factors associated
with linkage, adherence and retention in care do not
occur in isolation but are in fact complex and tightly
interwoven [43].
We first considered developing this method of synthe-
sis after searching for an appropriate way to synthesise a
large amount of qualitative systemic reviews. We wanted
to know what was available, what was the quality of the
evidence, and what new research questions should we
invest our time and resources into. In the context of the
pragmatic stance and the anticipated large number of
existing systematic reviews, a predetermined theoretical
framework [23] with broad categories was selected to
guide the aggregation and synthesis within this overview,
which built on the steps in methods development for
conducting overviews [24], QES [25, 26], systematic re-
view synthesis [19, 27, 28], meta-aggregation [9, 20, 21]
and framework synthesis [29, 30]. While conducting this
overview, a worked example of mega-ethnography [8]
was published. However, there was and there currently
is no specific guidance on conducting a pragmatic syn-
thesis in an overview of qualitative review-level evidence.
We initially mapped out broad steps aligned to conven-
tional systematic review methods with deviations in the
analysis. As we worked through and reflected on the
synthesis, we found it critical to identify the theoretical
framework that had broad categories within which we
could extract data at the outset of the protocol, and to
produce lines of action and recommendations at the end
of synthesis. We then refined the method into 8 steps
which we illustrated in this manuscript. The steps in-
clude the following: (1) identify a clearly defined review
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question and objectives, (2) identify a theoretical frame-
work or model, (3) decide on criteria for considering re-
views for inclusion, (4) conduct searching and screening,
(5) conduct quality appraisal of the included studies (al-
though some may prefer not too), (6) data extraction
and categorisation, (7) present and synthesise the find-
ings, and (8) transparent reporting.
Before embarking on new systematic reviews, it is im-
portant for authors and review teams to take stock of
existing evidence and minimise the risk of creating re-
search waste. This overview highlights the need for more
qualitative review-level evidence, with high methodo-
logical quality, that explores the complex relationships
between structural factors and adherence, between
sociodemographic factors such as community violence
and retention, and the experiences of growing up with
HIV in low- and middle-income countries, specifically in
the populations of youth, women and key populations.
Strengths and limitations of the mega-aggregative
framework approach
Through our worked application, we identified benefits of
the mega-aggregative framework approach. First, the prag-
matic philosophical underpinning promoted the aggrega-
tion of findings and a clear identification of where
research is lacking, the quality of the research and the lo-
cation of research across socio-economic statuses of coun-
tries. Some overviews only provide a synthesis without
clear directives for policy and practice, and authors may
see this as optional—leaving the reader to deduce or draw
their own conclusions on the way forward. Using the
mega-aggregative framework approach, the lines of action
provide researchers and funders with clear guidance on
where to direct funding and resources or to develop new
research questions. It also provides practitioners with a
comprehensive selection of the available evidence and the
appraised quality of the evidence. A second benefit is that
a mega-aggregation framework synthesis can be con-
ducted in a relatively short amount of time. Other
methods of synthesis can be iterative as review authors
make sense of their own subjective interpretations. Using
a framework with broad categories allows for linear work-
ing and promotes the comparing of findings between re-
view authors. Using this method, the number of findings
is counted and reported, with research gaps and recom-
mendations for policy and practice being apparent imme-
diately. Concrete time is then spent of the lines of action.
This approach is feasible and can be especially attractive
to novice researchers. A third benefit is the attention to
the methodological quality of included systematic reviews;
however, the benefits of the method proposed are not
without its challenges or limitations. While there is on-
going debate [64, 65] about when, within which paradig-
matic stance, and whether to conduct critical appraisal of
included studies within a qualitative evidence synthesis,
we included methodological appraisal as a step in the
mega-aggregative approach. We found very few high-
quality reviews examining self-reported barriers and facili-
tators to linkage, adherence to ART and retention in care
for children and adults. In the results, we presented an ag-
gregation of findings and the provided a separate para-
graph detailing the findings of the high-quality included
reviews. This does not imply that the primary studies in-
cluded in the reviews are of low quality, as we only
assessed the methodological quality of the systematic re-
views. We used guidance from recent methodological pa-
pers [25, 26, 76–78] in the field of critical appraisal to
revise the JBI-SR Checklist [78] for our overview and to
determine our decision rules for overall quality of the re-
views. The appraisal of the reviews challenged us as au-
thors to think reflexively about the domains that
influenced the quality of the reviews and the items on the
appraisal tool that explored these domains. As with over-
views of qualitative systematic reviews, the area for
method development in critical appraisals of QES is
understudied and tools for critical appraisal of QES are
still under development. Using the mega-aggregative
framework approach can limit the author team in their
creativity or conceptual modelling of new theories. The
mega-aggregative framework approach uses an existing
framework and pragmatic approach that can make the
analysis process mechanical and sometimes force the data
into predefined categories. When we refined the steps of
the method, we included selection of the framework as a
critical step as much of the synthesis is defined by it.
Using a framework with broad categories is preferable.
Additionally, we experienced challenges related to the def-
initions of the outcomes of interest, namely, linkage, ad-
herence and retention in care, in the included qualitative
reviews, even though these were pre-specified in the
protocol. In quantitative research, measurements are used
to determine adherence, whereas qualitative data may be
broader. We discussed these in the author team and de-
cided to use overarching definitions and broad categorisa-
tion. It is recommended that future qualitative research
interrogate the conceptual definitions of linkage, adher-
ence and retention in care for PLHIV. We were chal-
lenged by our own assumptions that the pragmatic
aggregative nature of the proposed synthesis would be eas-
ily applied to sub-group analysis. We intended to explore
the data by subgroups for children 0–13 years, young
people and adolescents, perinatally infected adolescents
and adult subgroup populations, but due to the different
reporting methods and study designs, we were unable to
provide a detailed synthesis of themes for these subgroups.
We were also unable to group specific themes to specific
population groups or contexts. However, we grouped chil-
dren and youth as up to 24 years and adults as our second
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population group. Furthermore, we found a high propor-
tion of reviews to be conducted in low- and middle-
income countries. We conducted the aggregation for all
studies and included evidence annexes indicating the
socio-economic country grouping as low, middle, or high
for each reference. Lastly, the synthesis of the findings was
limited to the included review authors’ interpretation of
the data and we included the primary study data as per
the review authors’ description. It does become challen-
ging for research synthesis as the production of QES is in-
creasing and the risk of sampling and re-interpretation of
the same primary studies for different outcomes and ob-
jectives through different paradigmatic lenses. We ex-
tracted themes from the reviews as per the authors’
interpretation. However, using guidance from meta-
aggregation [9, 22], we only included themes that were
considered unequivocal, meaning the themes were sup-
ported with evidence in the included review. We provided
transparent decision-making notes and evidence annexes
to this manuscript to contribute to the trustworthiness of
the findings of this overview.
Conclusion
This paper describes the development and illustrates the
first application of mega-aggregation framework synthe-
sis for QES. The use of overviews to provide a synthesis
of the existing review-level evidence is expected to in-
crease as the pool of systematic reviews continues to
grow. As with all research designs dependent on the re-
search question and available resources, the aims and
scope of QES—at review and overview level—are varied.
Mega-aggregative framework synthesis is feasible and
easy to implement and follows a linear process. Author
teams interested in timeous and pragmatic ways to go
beyond scoping reviews or evidence gap maps, into cre-
ating synthesised statements with practical lines of ac-
tion and recommendations, are encouraged to
experiment and utilise the illustrated innovative method
of mega-aggregative framework synthesis for use in over-
views of qualitative systematic reviews. Further evalu-
ation and development of this method is needed to test
its utility with different types of data and in comparison,
to different approaches in qualitative synthesis.
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